Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia

Leukemia

Volumn 16, Issue 3, 2002, Pages 368-375

  Boeckx, N ^a,b   Willemse, M J ^a   Szczepanski, T ^a,c   van der Velden, V H J ^a   Langerak, A W ^a   Vandekerckhove, P ^b   van Dongen, J J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

AML; Chromosome aberrations; Fusion genes; Ig TCR gene rearrangements; MRD; RAG1; RAG2

Indexed keywords

BCR ABL PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; ONCOPROTEIN; RAG1 PROTEIN; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 16; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FUSION GENE; GENE EXPRESSION; GENE REARRANGEMENT; GENE SEQUENCE; GENE TARGETING; GENETIC COMPLEMENTATION; GENETIC TRANSCRIPTION; HETERODUPLEX ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 85014205264     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402387     Document Type: Article

References (36)

1. Detection of minimal residual disease in acute leukemia patients
2. Characterization of aberrant phenotypes in acute myeloblastic leukemia
3. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
4. Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias
5. T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
6. Clinical relevance of immunophenotypic and immunogenotypic analysis in acute non-lymphoblastic leukaemia
7. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia
8. Immunoglobulin heavy chain and T-cell receptor gamma and beta chain gene rearrangements in acute myeloid leukemias
9. Immunoglobulin and T-cell receptor gene rearrangements in acute non-lymphocytic leukemias. Analysis of 54 cases and a review of the literature
10. Gene rearrangement in acute non-lymphoblastic leukaemia: Correlation with morphological and immunophenotypic characteristics of blast cells
11. Rearrangements of T-cell receptor delta, gamma and beta genes in acute myeloid leukemia coexpressing T-lymphoid features
12. T cell receptor delta gene rearrangements occur predominantly in immature myeloid leukemias exhibiting lineage promiscuity
13. The t(6;11)(q27;q23) translocation in acute leukemia: A laboratory and clinical study of 30 cases. EU Concerted Action 11q23 Workshop participants
14. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants
15. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal acute leukemia
16. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia
17. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1, 612 patients entered into the MRC AML 10 trial
18. Proposal for the classification of the acute leukemias
19. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques
20. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects
21. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: Recommendations for optimal results
22. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis
23. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia
24. Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: Recommendations for optimal results
25. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of CONCERTED ACTION: Investigation of Minimal Residual Disease in Acute Leukemia
26. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage
27. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
28. Unravelling human T-cell receptor junctional region sequences
29. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821
30. Low frequency of RT-PCR-detectable chromosome aberrations in relapsed acute myeloid leukemia (AML): Implications for detection of minimal residual disease (MRD)
31. Immunoglobulin kappa gene rearrangements between the kappa deleting element and Jkappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis
32. Heterogeneity of V delta 2 TCR delta gene rearrangements in acute myeloid leukemia
33. TCR delta gene rearrangements in acute myeloid leukemia with T-lymphoid antigen expression
34. Immunophenotypical detection of minimal residual disease in acute leukemia
35. Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, 'minor' D segments or D-D recombination